Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
PTCT:NASDAQ
PTC Therapeutics, Inc.
$68.59
-3.19%
(-2.26) 1D
$68.69
+0.15% (+0.10)
Pre-market
Closed: Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTCT...
Open
$70.79
High
$71.00
Low
$68.52
Mkt. cap
5.69B
Avg. vol.
989.95K
Volume
250.00
P/E ratio
8.82
52-wk high
$87.50
52-wk low
$35.95
EPS
$7.78
Beta
0.56
Shares outstanding
82.78M
No. of employees
991
News stories
From sources across the web
Profile
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
About PTC Therapeutics, Inc.
CEOMatthew B. Klein
Employees991
FoundedJan 1, 1998
HeadquartersWarren, New Jersey, United States
SectorBiotechnology
Websiteptcbio.com
Next call in 13 days
Thu, May 7, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.44 est.)USD
Revenue / Estimate
-/ (233.64M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.18B
178.88M
211.01M
164.68M
Cost of goods sold
121.84M
124.41M
115.94M
140.08M
Cost of revenue
121.84M
124.41M
115.94M
140.08M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
80.96M
85.26M
84.05M
96.87M
Operating expense
84.76M
89.32M
91.58M
106.22M
Total operating expenses
206.59M
213.73M
207.52M
246.30M
Operating income
969.50M
-34.86M
3.49M
-81.62M
Other non operating income
2.44M
2.96M
102.00K
-7.65M
EBT including unusual items
929.83M
-71.05M
-23.07M
-139.08M
EBT excluding unusual items
931.45M
-70.95M
-31.40M
-150.16M
Income tax expense
63.27M
-6.20M
-38.97M
-4.12M
Effective tax rate
6.80%
8.73%
168.89%
2.96%
Other operating expenses
-
-
-
-
Net income
866.56M
-64.85M
15.90M
-134.96M
Net profit margin
73.68%
-36.25%
7.53%
-81.96%
Earnings per share
10.04
-0.83
0.19
-1.80
Interest and investment income
17.24M
20.99M
19.09M
2.14M
Interest expense
-51.34M
-51.35M
-51.68M
-57.32M
Net interest expenses
-34.09M
-30.36M
-32.59M
-55.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
976.72M
-27.28M
14.60M
-68.72M
Gain or loss from assets sale
77.00K
-
53.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer